News

STRATA Skin Sciences Engages in Insightful Fireside Chat Events

STRATA Skin Sciences Engages in Insightful Fireside Chat Events

STRATA Skin Sciences Highlights Its Innovations at Virtual Summit

HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leading medical technology company, is focused on advancing the treatment of skin conditions through groundbreaking products. The company is excited to announce that President and CEO Dr. Dolev Rafaeli will engage in a fireside chat at the upcoming Maxim Healthcare Virtual Summit. This modern conference, taking place on October 15 – 17, 2024, will feature discussions that promise to offer valuable insights into the future of dermatology.

About the Conference and Chat Session

The event will be held virtually, allowing participants from across the industry to join without the constraints of location. Dr. Rafaeli will share the stage with Maxim’s Director of Research and Senior Healthcare Analyst, Anthony Vendetti, enhancing the dialogue surrounding current industry trends and STRATA's innovations. The chat is scheduled for October 16, at 11:30 AM ET, making it an accessible opportunity for stakeholders and interested parties to learn more about STRATA’s strategies and future plans.

One-on-One Meetings with STRATA Leadership

In addition to the fireside chat, attendees will have the opportunity to meet one-on-one with Dr. Rafaeli and STRATA's Vice President of Finance, John Gillings. These private sessions provide registered investors a chance to discuss business strategies, product developments, and the company’s vision for the future of dermatology directly with its leadership.

Company Overview

STRATA Skin Sciences continues to push the boundaries of medical technology with their focus on innovative treatments for dermatologic conditions. Their product offerings include the XTRAC excimer laser, VTRAC lamp systems, and the TheraClear X Acne Therapy System. Each of these products is designed to deliver effective treatments for conditions such as psoriasis, vitiligo, and acne, showcasing STRATA's commitment to improving patient outcomes.

Innovative Partnership Program

STRATA operates under a unique Partnership Program that stands out in the industry. This program allows practices to utilize advanced technologies without the hefty expense of purchasing devices outright. Instead, STRATA offers a fee per treatment model, which includes comprehensive on-site training, installation, maintenance services, and customer support. This approach not only fosters a productive working relationship but also ensures that treatment providers are well-equipped to offer state-of-the-art solutions to their patients.

Looking Forward

As STRATA Skin Sciences continues to innovate and enhance its product offerings, participation in events like the Maxim Healthcare Virtual Summit is crucial for engaging with investors and industry professionals. The insights shared during these chats not only highlight the company's commitment to transforming dermatologic treatments but also reinforce their position as a thought leader in the medical technology space.

While the company remains optimistic about its future endeavors, they are cognizant of the challenges that can influence their operational landscape. The team is dedicated to navigating these challenges and continuing to deliver innovative solutions to meet the needs of their patients and partners.

Frequently Asked Questions

What is STRATA Skin Sciences?

STRATA Skin Sciences is a medical technology company specializing in the development and commercialization of products for dermatologic treatments.

Who will participate in the fireside chat?

President and CEO Dr. Dolev Rafaeli will participate, along with Anthony Vendetti, Director of Research at Maxim.

When is the fireside chat scheduled?

The chat is scheduled for October 16, 2024, at 11:30 AM ET.

What products does STRATA offer?

STRATA’s product lineup includes the XTRAC laser, VTRAC lamp systems, and the TheraClear X Acne Therapy System.

How can investors contact STRATA Skin Sciences?

Investors can reach out through CORE IR at 516-222-2560 or by email at IR@strataskin.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Advances in AI and Digital R&D Innovation by ICON plc

Updated Category News Views 227

Recent Developments in AI and Digital Innovation by ICON plc ICON plc, a globally recognized clinical research organization (NASDAQ: ICLR), has recently conducted an extensive survey exploring the integration of Artificial Intelligence (AI) and digital tools within clinical research. Engaging with over 100 professionals in the biotech and pharmaceutical industries across...

Continue Reading
Tesla's Self-Driving Claims Under Fire: Industry Reactions

Updated Category News Views 167

Tesla's License Suspension in California Recently, a court in California announced a significant development affecting Tesla Inc. (NASDAQ: TSLA). The court decided to suspend Tesla's license to sell vehicles for 30 days due to a lawsuit concerning misleading claims about the company's Full Self-Driving (FSD) technology. If Tesla does not adapt its policies within 90 days,...

Continue Reading
Sunnova Energy Faces Challenges Amid Revenue Declines in 2024

Updated Category News Views 384

Sunnova Energy Experiences Financial Struggles Sunnova Energy International Inc. (NOVA) has encountered a challenging period, with its shares trading lower in the premarket on Monday following a disappointing report detailing its fourth quarter and full-year financial results. The financial landscape for Sunnova shows a revenue of $224.127 million, which unfortunately...

Continue Reading
Kerusso's Important Contributions in Faith and Community Work

Updated Category News Views 133

Kerusso's Inspiring Charitable Contributions in 2025 Kerusso Activewear, a prominent Christian apparel and gift brand, has ended the year with a remarkable achievement of over $400,000 in charitable contributions. This reflects their steadfast commitment to enriching lives through faith-based approaches and generous support for individuals in need. Growing Demand for...

Continue Reading
Prelude Therapeutics and Incyte Join Forces for JAK2JH2 Inhibitor

Updated Category News Views 101

Prelude Therapeutics Partners with Incyte on JAK2V617F Program Incyte establishes exclusive option to acquire Prelude’s innovative programs These inhibitors have the potential to modify disease outcomes in patients with myeloproliferative neoplasms (MPNs) Prelude Therapeutics, a clinical-stage oncology company, has recently made headlines with an exciting announcement...

Continue Reading